GYRE THERAPEUTICS, INC. [GYRE] - appoints new directors

Effective August 1, 2026, GYRE appoints Yue Xiong, Ph.D. as a Class I director, Maxwell Kirkby as a Class II director and member of the Compensation Committee, and Claire Weston, Ph.D. as a Class III director and member of the Audit Committee, enhancing the Board's expertise in biopharmaceuticals.

View source filing ↗